Evidence map›Paper›PMID 39036543›Full record

ArticleThe Lancet regional health. Europe2024

Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912].

Maria Lucia Iacovino, Simone Celant, Luca Tomassini, Laura Arenare, Andrea Caglio, Andrea Canciello, Flavio Salerno, Pier Paolo Olimpieri, Susanna Di Segni, Antonella Sferrazza and 9 more

RetractedAbstract readPublished ErratumRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet regional health. Europe, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Maria Lucia IacovinoNational Cancer Institute, IRCCS Fondazione G.Pascale, Naples, Italy.
Simone CelantItalian Medicines Agency, Rome, Italy.
Luca TomassiniItalian Medicines Agency, Rome, Italy.
Laura ArenareNational Cancer Institute, IRCCS Fondazione G.Pascale, Naples, Italy.
Andrea CaglioDepartment of Oncology, University, Ordine Mauriziano Hospital Umberto I, Turin, Italy.
Andrea CancielloNational Cancer Institute, IRCCS Fondazione G.Pascale, Naples, Italy.
Flavio SalernoDepartment of Oncology, University, Ordine Mauriziano Hospital Umberto I, Turin, Italy.
Pier Paolo OlimpieriItalian Medicines Agency, Rome, Italy.
Susanna Di SegniItalian Medicines Agency, Rome, Italy.
Antonella SferrazzaItalian Medicines Agency, Rome, Italy.
Maria Carmela PiccirilloNational Cancer Institute, IRCCS Fondazione G.Pascale, Naples, Italy.
Giordano Domenico BerettaMedical Oncology, Hospital, Pescara, Italy.
Carmine PintoMedical Oncology, Comprehensive Cancer Centre, AUSL-IRCCS di Reggio Emilia, Italy.
Livio BlasiMedical Oncology, Civic Hospital Cristina Benfratelli, Palermo, Italy.
Saverio CinieriMedical Oncology and Breast Unit, Perrino Hospital, Brindisi, Italy.
Luigi CavannaMedical Oncology and Hematology, Civil Hospital, Piacenza, Italy.
Massimo Di MaioDepartment of Oncology, University of Turin, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
Pierluigi RussoItalian Medicines Agency, Rome, Italy.
Francesco PerroneNational Cancer Institute, IRCCS Fondazione G.Pascale, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.lanepe.2024.100912.].

Identifiers

PMID39036543
PMCPMC11257776

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.